BPC‑157 10mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview BPC-157 is a research peptide studied for its role in cellular signalling, regenerative pathways and gastrointestinal protective mechanisms. This 10 mg lyophilized peptide supports controlled evaluation of tissue-repair modelling and recovery biology in laboratory environments.   Peptide Overview Interest in gastric-derived protective peptides emerged in the early 1990s. Between 2005 and 2025 BPC-157 became a widely used reference compound in studies evaluating angiogenesis, cellular migration, tendon modelling and microvascular repair mechanisms.   Historical Background and Scientific Context From 2010 to 2025 BPC-157 research expanded significantly as laboratories examined recovery pathways, regenerative tissue dynamics and endothelial stability. Its consistent analytical profile and structural reliability make it suitable for controlled in-vitro models.   Mechanistic Focus in Research

• Angiogenesis-related signalling pathways
• Tendon and ligament recovery modelling
• Endothelial and microvascular response analysis
• Gastrointestinal protective mechanism research
• Regenerative peptide comparison studies

  Analytical Verification (COA) Independent Liquilabs analysis confirms full analytical validation for Batch GF082025014. Key results include:

• Purity: 99.8 percent
• Assay Content: 14.57 mg
• Identification – Retention Time: 0.988
• Identification – Spectrum: 992
• Endotoxins: detected but below 0.01 EU per mg
• Microbial Growth: not detected for aerobic count or yeast or mold
• Heavy Metals: not detected including arsenic cadmium lead mercury nickel cobalt vanadium

All analytical values are obtained using validated chromatographic, spectroscopic and microbiological procedures ensuring complete traceability and scientific transparency.   Research Applications

• Tendon and ligament recovery modelling
• Microvascular and angiogenesis pathway research
• Cellular migration and wound-response studies
• Gastrointestinal protection modelling
• Regenerative biology comparison analysis

 

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Researched and analysed with Liquilabs s.r.o. Czechia
• 99.8 percent purity with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin below 0.01 EU per mg
• Batch GF082025014 – Published August 2025
• EU shipments include bacteriostatic water
• For research use only not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.